SHLTN — SHL Telemedicine Cashflow Statement
0.000.00%
- CH₣32.78m
- CH₣33.22m
- $57.08m
- 48
- 60
- 23
- 36
Annual cashflow statement for SHL Telemedicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5.7 | 0.278 | -13.9 | 0.215 | -6.86 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -0.034 | 0.203 | 14.9 | -3.68 | -1.09 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.27 | -0.727 | -6.45 | -3.74 | -1.24 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 10.8 | 4.68 | 0.185 | -0.073 | -1.5 |
Capital Expenditures | -1.97 | -1.77 | -3.26 | -6.9 | -5.49 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 4.45 | -5.88 | -37.7 | 0.471 | -3.85 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 2.47 | -7.65 | -41 | -6.43 | -9.35 |
Financing Cash Flow Items | — | — | — | -0.13 | -1.91 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -11.9 | 0.723 | 51.1 | -2.28 | 13.7 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.65 | -1.93 | 10.7 | -10.4 | 2.21 |